Cite
CD47-mediated immune evasion in early-stage lung cancer progression.
MLA
Chuang, Cheng-Hao, et al. “CD47-Mediated Immune Evasion in Early-Stage Lung Cancer Progression.” Biochemical and Biophysical Research Communications, vol. 720, Aug. 2024, p. 150066. EBSCOhost, https://doi.org/10.1016/j.bbrc.2024.150066.
APA
Chuang, C.-H., Zhen, Y.-Y., Ma, J.-Y., Lee, T.-H., Hung, H.-Y., Wu, C.-C., Wang, P.-H., Huang, C.-T., Huang, M.-S., Hsiao, M., Lee, Y.-R., Huang, C.-Y. F., Chang, Y.-C., & Yang, C.-J. (2024). CD47-mediated immune evasion in early-stage lung cancer progression. Biochemical and Biophysical Research Communications, 720, 150066. https://doi.org/10.1016/j.bbrc.2024.150066
Chicago
Chuang, Cheng-Hao, Yen-Yi Zhen, Juei-Yang Ma, Tai-Huang Lee, Huei-Yang Hung, Chun-Chieh Wu, Pei-Hui Wang, et al. 2024. “CD47-Mediated Immune Evasion in Early-Stage Lung Cancer Progression.” Biochemical and Biophysical Research Communications 720 (August): 150066. doi:10.1016/j.bbrc.2024.150066.